Larue Holteen, RN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 107 Commercial St, Mashpee, MA 02649 Phone: 508-477-7090 Fax: 508-477-7028 |
Ms. Barbara A Murphy, APRN Clinical Nurse Specialist - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: Mashpee Mental Health Center, 400 Nathan Ellis Hwy. - #1, Mashpee, MA 02649 Phone: 508-477-5488 Fax: 508-477-9334 |
News Archive
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Among the many challenges families caring for individuals with autism spectrum disorders face, perhaps the most difficult of all arrive "when the school bus stops." When a child with autism ages out of systems and supports designed for those up to ages 18-21, families face the daunting challenge of finding new resources and creating new communities for their children. Unfortunately, finding necessary services and supports can be very difficult.
More than 60 percent of American adults weigh more than is healthy, which results in increased health issues for the patient and high health care costs.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, has donated a number of free ReCell devices and sent personnel experienced in burn treatment to provide any support requested by authorities in Taiwan, where hundreds of people have been left seriously burned in a mass casualty event at a waterpark.
Some General Practitioners (GPs) over-estimate adverse risks associated with the use of beta blocker drugs in the fight against heart disease, according to research launched today at the British Pharmaceutical Conference (BPC) in Manchester.
› Verified 4 days ago